TearLab (OTCMKTS:TEAR – Get Free Report) and Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.
Analyst Ratings
This is a summary of recent ratings and target prices for TearLab and Rapid Micro Biosystems, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TearLab | 0 | 0 | 0 | 0 | 0.00 |
| Rapid Micro Biosystems | 1 | 0 | 2 | 0 | 2.33 |
Rapid Micro Biosystems has a consensus target price of $6.00, indicating a potential upside of 198.51%. Given Rapid Micro Biosystems’ stronger consensus rating and higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than TearLab.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| TearLab | N/A | N/A | N/A |
| Rapid Micro Biosystems | -145.81% | -131.52% | -67.48% |
Institutional & Insider Ownership
52.6% of Rapid Micro Biosystems shares are held by institutional investors. 5.2% of TearLab shares are held by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares TearLab and Rapid Micro Biosystems”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TearLab | N/A | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems | $33.59 million | 2.76 | -$47.12 million | ($1.12) | -1.79 |
TearLab has higher earnings, but lower revenue than Rapid Micro Biosystems.
Summary
Rapid Micro Biosystems beats TearLab on 6 of the 9 factors compared between the two stocks.
About TearLab
TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.
About Rapid Micro Biosystems
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Receive News & Ratings for TearLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TearLab and related companies with MarketBeat.com's FREE daily email newsletter.
